Apoptosis Prevention Therapy for the Treatment of Retinal Degeneration: Basic Science to Clinical Application

视网膜变性的细胞凋亡预防疗法：基础科学到临床应用

• 批准号: 174403
• 负责人: Tsilfidis Catherine
• 金额: --
• 依托单位: Ottawa Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2008
• 资助国家: 加拿大
• 起止时间: 2008-10-01 至 2009-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=174403&lang=en
• 关键词: Apoptosis; Gene Therapy; Retinal Degeneration

Cell death via apoptosis is the final common pathway for many forms of retinal disease, including glaucoma, retinitis pigmentosa, retinal ischemia, age-related macular degeneration and diabetic retinopathy. As such, any gene therapy strategy which target

细胞凋亡导致的细胞死亡是许多视网膜疾病的最终共同途径，包括青光眼、视网膜色素变性、视网膜缺血、年龄相关性黄斑变性和糖尿病视网膜病变。 因此，任何靶向的基因治疗策略，